Wall Street brokerages expect that Clorox Company (The) (NYSE:CLX) will announce sales of $1.48 billion for the current quarter, Zacks Investment Research reports. Six analysts have provided estimates for Clorox Company (The)’s earnings. The lowest sales estimate is $1.46 billion and the highest is $1.49 billion. Clorox Company (The) posted sales of $1.44 billion during the same quarter last year, which suggests a positive year over year growth rate of 2.8%. The company is scheduled to announce its next quarterly earnings report on Wednesday, November 1st.

On average, analysts expect that Clorox Company (The) will report full year sales of $1.48 billion for the current financial year, with estimates ranging from $6.12 billion to $6.20 billion. For the next year, analysts forecast that the business will post sales of $6.36 billion per share, with estimates ranging from $6.30 billion to $6.41 billion. Zacks’ sales calculations are a mean average based on a survey of research analysts that follow Clorox Company (The).

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.65 billion. During the same quarter in the prior year, the company posted $1.30 earnings per share. Clorox Company (The)’s quarterly revenue was up 2.9% on a year-over-year basis.

Several research analysts have weighed in on CLX shares. Deutsche Bank AG reissued a “hold” rating and issued a $137.00 price target (up from $126.00) on shares of Clorox Company (The) in a report on Saturday, July 22nd. BMO Capital Markets reissued a “buy” rating and issued a $136.00 price target on shares of Clorox Company (The) in a report on Thursday, May 4th. Royal Bank Of Canada reissued a “hold” rating and issued a $115.00 price target on shares of Clorox Company (The) in a report on Wednesday, August 2nd. Zacks Investment Research cut shares of Clorox Company (The) from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Finally, BidaskClub cut shares of Clorox Company (The) from a “sell” rating to a “strong sell” rating in a report on Monday, July 24th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company. Clorox Company (The) has an average rating of “Hold” and a consensus price target of $129.05.

ILLEGAL ACTIVITY NOTICE: “Brokerages Expect Clorox Company (The) (CLX) Will Post Quarterly Sales of $1.48 Billion” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/26/brokerages-expect-clorox-company-the-clx-will-post-quarterly-sales-of-1-48-billion.html.

In other news, EVP James E. Foster sold 9,861 shares of the firm’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the transaction, the executive vice president now directly owns 22,069 shares of the company’s stock, valued at $3,056,777.19. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Jon M. Balousek sold 9,223 shares of the firm’s stock in a transaction that occurred on Wednesday, August 23rd. The stock was sold at an average price of $138.87, for a total transaction of $1,280,798.01. Following the transaction, the senior vice president now directly owns 20,614 shares in the company, valued at $2,862,666.18. The disclosure for this sale can be found here. 0.74% of the stock is currently owned by company insiders.

Several hedge funds and other institutional investors have recently made changes to their positions in CLX. American Beacon Advisors Inc. purchased a new position in shares of Clorox Company (The) during the first quarter worth about $104,000. Parkside Financial Bank & Trust boosted its position in shares of Clorox Company (The) by 3.8% in the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock worth $107,000 after buying an additional 29 shares during the period. Valley National Advisers Inc. boosted its position in shares of Clorox Company (The) by 0.6% in the second quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock worth $115,000 after buying an additional 5 shares during the period. Blue Chip Partners Inc. boosted its position in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock worth $122,000 after buying an additional 6 shares during the period. Finally, Sun Life Financial INC boosted its position in shares of Clorox Company (The) by 10,344.4% in the second quarter. Sun Life Financial INC now owns 940 shares of the company’s stock worth $125,000 after buying an additional 931 shares during the period. 69.83% of the stock is currently owned by institutional investors.

Shares of Clorox Company (NYSE CLX) traded up 0.37% on Friday, reaching $137.48. The company had a trading volume of 367,640 shares. Clorox Company has a 12 month low of $111.24 and a 12 month high of $141.76. The stock has a 50 day moving average price of $134.18 and a 200-day moving average price of $134.70. The company has a market capitalization of $17.74 billion, a price-to-earnings ratio of 25.77 and a beta of 0.40.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Get a free copy of the Zacks research report on Clorox Company (The) (CLX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.